Tirzepatide has emerged as a groundbreaking therapy for type 2 diabetes, offering promising effects. However, the price of this innovative drug and its access have become key concerns for patients and healthcare professionals. While tirzepatide has been approved by regulatory agencies, its expensive nature presents a significant obstacle to many.